Cargando…
RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893664/ https://www.ncbi.nlm.nih.gov/pubmed/33597207 http://dx.doi.org/10.1136/rmdopen-2021-001565 |
| _version_ | 1783653091097182208 |
|---|---|
| author | Strand, Vibeke |
| author_facet | Strand, Vibeke |
| author_sort | Strand, Vibeke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7893664 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78936642021-03-03 RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? Strand, Vibeke RMD Open Treatments BMJ Publishing Group 2021-02-17 /pmc/articles/PMC7893664/ /pubmed/33597207 http://dx.doi.org/10.1136/rmdopen-2021-001565 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Treatments Strand, Vibeke RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title | RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title_full | RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title_fullStr | RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title_full_unstemmed | RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title_short | RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? |
| title_sort | rmd commentary, jak kinase inhibitors: a preferred alternative to tnf inhibitors? |
| topic | Treatments |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893664/ https://www.ncbi.nlm.nih.gov/pubmed/33597207 http://dx.doi.org/10.1136/rmdopen-2021-001565 |
| work_keys_str_mv | AT strandvibeke rmdcommentaryjakkinaseinhibitorsapreferredalternativetotnfinhibitors |